← Back to Search

Behavioural Intervention

Neurofeedback for Anxiety

N/A
Waitlist Available
Led By Stefanie Russman Block, Ph.D
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Primary diagnosis of generalized anxiety disorder, social anxiety disorder, panic disorder, or illness anxiety disorder based on structured interview
Be between 18 and 65 years old
Must not have
Current diagnosis of Obsessive Compulsive Disorder or Posttraumatic Stress Disorder
History of serious neurological illness or medical condition compromising brain function
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 60 minutes
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to investigate how real-time brain activity feedback can help young adults with anxiety regulate their emotions. The researchers will use functional magnetic resonance imaging neurofeedback to see if individuals can control their brain activity

Who is the study for?
This trial is for young adults with anxiety disorders such as social anxiety, generalized anxiety, and panic disorder. Participants should be interested in using neurofeedback to potentially improve emotion regulation.
What is being tested?
The study tests if real-time feedback on brain activity (veritable-Neurofeedback) can enhance cognitive reappraisal ability better than sham Neurofeedback (placebo). It uses fMRI to monitor changes in the ventrolateral prefrontal cortex.
What are the potential side effects?
Since this trial involves fMRI and neurofeedback without drugs or invasive procedures, side effects are minimal but may include discomfort from lying still during the scan or mild headaches.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with an anxiety disorder.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have been diagnosed with OCD or PTSD.
Select...
I have a serious brain condition or illness affecting my brain function.
Select...
I have had a severe head injury with unconsciousness, hospital stay, or lasting effects.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 60 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 60 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in negative affect ratings of images from the International Affective Picture System (IAPS).
Secondary study objectives
Change in amygdala-vlPFC functional connectivity (baseline to transfer) from reappraise > look contrast.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Veritable-NFExperimental Treatment1 Intervention
Group II: Sham-NFActive Control1 Intervention

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,918 Previous Clinical Trials
2,740,062 Total Patients Enrolled
91 Trials studying Anxiety
41,884 Patients Enrolled for Anxiety
University of MichiganLead Sponsor
1,856 Previous Clinical Trials
6,435,140 Total Patients Enrolled
18 Trials studying Anxiety
9,812 Patients Enrolled for Anxiety
Stefanie Russman Block, Ph.DPrincipal InvestigatorUniversity of Michigan
1 Previous Clinical Trials
30 Total Patients Enrolled
1 Trials studying Anxiety
30 Patients Enrolled for Anxiety
~73 spots leftby May 2029
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top